BGR GOVERNMENT AFFAIRS

Lobbying for PTC THERAPEUTICS · Biopharmaceutical

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and PTC specifically.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.